RAPITEX (R) CRP NEW— 510(k) K903853

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K903853 for RAPITEX (R) CRP NEW, Substantially Equivalent on 1990-08-30. Applicant: Behring Diagnostics, Inc..

Clearance details

Applicant: Behring Diagnostics, Inc.
Product code: Code DCN
Advisory panel: Immunology
Date received: 1990-08-21
Decision date: 1990-08-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Somerville, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.